Back

Culprit-only versus multivessel percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock: an updated systematic review and meta-analysis

29 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Beyond the valve and vessel: systemic risk, inflammation, and complex interventions Primary Percutaneous Coronary Intervention (PCI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Valeria Yolotzin Gomez Lopez

Mexico City (Mexico)

4 More presentations in this session

Presentation thumbnail
Multi-level thromboinflammatory activation after TAVR: systemic, cellular, and platelet transcriptomic changes
Doctor D. Hesselbarth (Freiburg, DE)
Abstract
Presentation thumbnail
Prognostic value of TAPSE/sPAP ratio across cardiovascular–kidney–metabolic phenotypes after TAVI
Doctor K. Hu (Wuerzburg, DE)
Abstract
Presentation thumbnail
Systemic atherosclerosis assessment using lipoprotein(a) and angioscopy: a prospective study of cholesterol crystal detection
Doctor Y. Tanaka (Tokyo, JP)
Abstract
Presentation thumbnail
Safety and efficacy of intravascular lithotripsy-facilitated transcatheter aortic valve replacement: a systematic review and meta-analysis
Doctor D. Chekhava (Bronx, US)
Abstract

Access the full session

Session thumbnail
Beyond the valve and vessel: systemic risk, inflammation, and complex interventions

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Complete versus culprit-vessel only revascularization for patients with acute coronary syndromes and multivessel disease
2 September 2019
thumbnail
Congress Presentation
Complications of temporary mechanical circulatory support in cardiogenic shock: a systematic review and meta-analysis
20 March 2026
thumbnail
Congress Presentation
Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study.
3 September 2019
thumbnail
Congress Session
STEMI: state of the art
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources